Products for Research Use Only
RegisterLogin

JD-02

CAT: 0804-HY-162365Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-162365Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JD-02 is a novel Hsp90 inhibitor. JD-02 can induce autophagy and apoptosis. JD-02 increses the level of reactive oxygen species[1].
UNSPSC
12352005
Target
Apoptosis; Autophagy; HSP
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jd-02.html
Solubility
10 mM in DMSO
Smiles
CC1=NN(C2=CC=C(C(N)=O)C(N[C@@H]3CC[C@@H](O)CC3)=C2)C4=C1/C(CC(C)(C)C4)=N/N
Molecular Formula
C23H32N6O2
Molecular Weight
424.54
References & Citations
[1]Lan N, et al. JD-02, a novel Hsp90 inhibitor, induces ROS/SRC axis-dependent cytoprotective autophagy in colorectal cancer cells. Mol Carcinog. Published online February 27, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-18697-01JD-5037
HY-145795-01OF-02
HY-P991239NM-02
HY-108262UCN-02
HY-203817-01IITZ-02
HY-W688571T-02
HY-100115-01TA-02
HY-121490IMM-02
HY-155108OATD-02
HY-160228ORN 02

Alternative Products

CatalogName
T209229-01JD-02
MBS3601626-01JD-5037
FJ166461-01JD 5037
GTR19272725-01JD-13
sc-130460EDEM2 (JD-32)
A20837-50JD-5037 50mg
A20837-25JD-5037 25mg
A20837-5JD-5037 5mg
A20837-1JD-5037 1mg
A20837-100JD-5037 100mg

Popular Products